These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2878155)

  • 1. Toxicity of leukaemia therapy in children with Down syndrome.
    Peeters MA; Poon A; Zipursky A; Lejeune J
    Lancet; 1986 Nov; 2(8518):1279. PubMed ID: 2878155
    [No Abstract]   [Full Text] [Related]  

  • 2. Excessive chemotherapy-related myelotoxicity in children with Down syndrome and acute lymphoblastic leukaemia.
    Blatt J; Albo V; Prin W; Orlando S; Wollman M
    Lancet; 1986 Oct; 2(8512):914. PubMed ID: 2876340
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical pharmacological trial of guanazole.
    Yakar D; Holland JF; Ellison RR; Freeman A
    Cancer Res; 1973 May; 33(5):972-5. PubMed ID: 4512954
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute lymphocytic leukemia in children: maintenance therapy with methotrexat administered intermittently. Acute Leukemia Group B.
    JAMA; 1969 Feb; 207(5):923-8. PubMed ID: 4303512
    [No Abstract]   [Full Text] [Related]  

  • 5. Over one and half years unmaintained remission in acute leukaemia.
    Aboul-Enein MI; Kotb A; Mohieddin O
    Gaz Egypt Paediatr Assoc; 1974 Apr; 22(2):169-70. PubMed ID: 4532656
    [No Abstract]   [Full Text] [Related]  

  • 6. Topical folinic acid therapy in methotrexate-induced oral ulceration.
    Barrett AP
    J Periodontol; 1986 May; 57(5):318-20. PubMed ID: 3486267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermittent therapy with 6-mercaptopurine (NSC-755) and methotrexate (NSC-740) given intravenously to adults with acute leukemia.
    Ellison RR; Hoogstraten B; Holland JF; Levy RN; Lee SL; Silver RT; Leone LA; Cooper T; Oberfield RA; Ten Pas A; Blom J; Jacquillat C; Haurani F
    Cancer Chemother Rep; 1972 Aug; 56(4):535-42. PubMed ID: 4507688
    [No Abstract]   [Full Text] [Related]  

  • 8. Severe oral ulceration in a patient taking low-dose methotrexate for rheumatoid arthritis.
    Pliskin ME; Lally ET; Quinn P
    Compend Contin Educ Dent (Lawrenceville); 1986 Jun; 7(6):430-3. PubMed ID: 3460734
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical characteristics and mechanisms involved in chemotherapy-induced oral ulceration.
    Barrett AP
    Oral Surg Oral Med Oral Pathol; 1987 Apr; 63(4):424-8. PubMed ID: 3472141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bone marrow necrosis. Apropos of 2 cases].
    Alegre Amor A; González Sarmiento R; Anta García JP; Moraleda JM; Del Cañizo Fernández C; López Borrasca A
    Sangre (Barc); 1985; 30(4-A):458-62. PubMed ID: 2933830
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of isolated central nervous system leukaemia on bone marrow remission and survival in childhood acute lymphoblastic leukaemia. A report for Children's Cancer Study Group.
    Lancet; 1981 Jun; 1(8235):1386-9. PubMed ID: 6113351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate-induced malabsorption in children with acute lymphoblastic leukaemia.
    Craft AW; Kay H; Lawson DN; McElwain TJ
    Br Med J; 1977 Dec; 2(6101):1511-2. PubMed ID: 271033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytogenetic studies in 45 patients with acute lymphocytic leukemia.
    Whang-Peng J; Freireich EJ; Oppenheim JJ; Frei E; Tjio JH
    J Natl Cancer Inst; 1969 Jun; 42(6):881-97. PubMed ID: 4240411
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapy of acute leukemia.
    Holland JF
    Hamatol Bluttransfus; 1970; 9():58-65. PubMed ID: 5279393
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical correlates of in vitro effect of methotrexate on acute leukemia blasts.
    Hryniuk WM; Bishop A; Foerster J
    Cancer Res; 1974 Oct; 34(10):2823-9. PubMed ID: 4547159
    [No Abstract]   [Full Text] [Related]  

  • 16. Bone-marrow toxicity of methotrexate: a reassessment.
    Douglas ID; Price LA
    Br J Haematol; 1973 May; 24(5):625-31. PubMed ID: 4514552
    [No Abstract]   [Full Text] [Related]  

  • 17. Oral methotrexate is as effective as intramuscular in maintenance therapy of acute lymphoblastic leukaemia.
    Chessells JM; Leiper AD; Tiedemann K; Hardisty RM; Richards S
    Arch Dis Child; 1987 Feb; 62(2):172-6. PubMed ID: 3469936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic importance of myelosuppression during maintenance treatment of lymphoblastic leukaemia. Leukaemia in Childhood Working Party of the Medical Research Council.
    Dolan G; Lilleyman JS; Richards SM
    Arch Dis Child; 1989 Sep; 64(9):1231-4. PubMed ID: 2684039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of refractory acute lymphoblastic leukemia with teniposide and cytarabine.
    Kamen BA; Casper J; Lauer S; Camitta BM; Holcenberg JS
    Cancer Treat Rep; 1986 Jul; 70(7):935-6. PubMed ID: 3459577
    [No Abstract]   [Full Text] [Related]  

  • 20. Bone-marrow lymphocytes in acute lymphoid leukaemia: effect of therapeutic regimes.
    Pushpa V; Till MM; Raynsford G; Hardisty RM
    Biomedicine; 1973 Jan; 19(1):11-5. PubMed ID: 4513753
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.